Seeing Is Believing
Currently out of the existing stock ratings of Kelechi Chikere, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst Kelechi Chikere, carries an average stock price target met ratio of 38.89% that have a potential upside of 51.7% achieved within 41 days.
Kelechi Chikere’s has documented 18 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VAXX, Vaxxinity at 29-Dec-2021.
Analyst best performing recommendations are on ALT (ALTIMMUNE).
The best stock recommendation documented was for ALT (ALTIMMUNE) at 12/23/2020. The price target of $24 was fulfilled within 56 days with a profit of $11.38 (90.17%) receiving and performance score of 16.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2020
$14
$9.47 (209.05%)
$15
3 months 9 days ago
(07-Nov-2025)
0/16 (0%)
$9.89 (240.63%)
Buy Since 02-Jun-2021
$12
$7.47 (164.90%)
$12
3 months 27 days ago
(20-Oct-2025)
0/21 (0%)
$8 (200.00%)
Buy Since 25-Sep-2020
$18
$13.47 (297.35%)
$20
6 months 3 days ago
(13-Aug-2025)
4/17 (23.53%)
$14.26 (381.28%)
214
Buy Since 12-Nov-2024
$26
6 months 3 days ago
(13-Aug-2025)
0/1 (0%)
$16.51 (173.97%)
Buy Since 01-Jun-2020
$25
$20.47 (451.88%)
$25
1 years 7 months 26 days ago
(21-Jun-2024)
3/15 (20%)
$18.59 (290.02%)
42
What Year was the first public recommendation made by Kelechi Chikere?